Quantcast

Latest brain metastases Stories

2010-04-29 08:00:00

ATLANTA and PHILADELPHIA, April 29 /PRNewswire/ -- At the 2010 American Association of Neurological Surgeons (AANS) Annual Meeting, May 1-5 at the Pennsylvania Convention Center, Elekta will host a series of presentations highlighting Elekta Neuromag®, a tool that measures and records brain activity using magnetoencephalography (MEG) technology. Led by Froedert & Medical College of Wisconsin neurosurgeon, Brian Kopell, M.D., the sessions will take place at Elekta...

2010-01-26 06:30:00

MISSISSAUGA, ON, Jan. 26 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), announced that the FDA has advised the Company that it may now enroll patients at US clinical sites into two ongoing randomized, double-blind Phase II trials of its lead product, nimotuzumab. One of the two trials is in non-small-cell lung cancer (NSCLC) patients who are ineligible for curative treatment and being treated palliatively and the other in patients with brain metastases from NSCLC....

46cc534a0fae79d6b039eef9687929061
2009-12-20 13:25:50

Up to 25% of cancer patients develop metastases in the brain "“ often long after successful treatment of the primary tumor. In almost all such cases, the prognosis is poor. The mechanisms responsible for the appearance of brain metastases have long been mysterious. Now a research team led by neurologist Dr. Frank Winkler of LMU Munich has followed, in real time, the steps that lead some tumor cells to establish metastases, while others fail to form new tumors. The team also discovered...

2009-12-10 12:14:42

New tool is first evidence-based, multidisciplinary treatment guidelines developed New treatment guidelines for patients with brain metastases are now available from the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS). David Andrews, M.D., F.A.C.S., professor and vice-chair of Clinical Services in the Department of Neurological Surgery at Jefferson Hospital for Neuroscience, served as a member of the task force chosen to draft this new,...

2009-10-26 23:51:26

The first national treatment guidelines for brain metastases, which account for nearly 500,000 new cancers annually in the United States, were released today at the Congress of Neurological Surgeons in New Orleans. The guidelines were developed by a 20-member panel in various specialties over the last year after reviewing the literature and reaching a consensus for different treatments. The panel was headed by neurosurgeon Steven Kalkanis, M.D., co-director of the Hermelin Brain Tumor Center...

2009-10-06 11:15:15

Addition of whole brain radiation to treatment regimen results in greater learning and memory problems Cancer patients who receive stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) for the treatment of metastatic brain tumors have more than twice the risk of developing learning and memory problems than those treated with SRS alone, according to researchers at The University of Texas M. D. Anderson Cancer Center. The findings of the phase III randomized trial are...

2009-09-22 07:52:23

Whole-brain radiotherapy should not be given routinely to all patients whose cancer has spread to the brain, say researchers who found that using it after surgery or radiosurgery in patients with a limited number of brain metastases and stable cancer in the rest of the body did not extend lives or help patients remain functionally independent for longer. In the largest study to date on the issue, scientists reported at Europe's largest cancer congress, ECCO 15 "“ ESMO 34 [1], in Berlin...

2009-01-05 16:00:00

MISSISSAUGA, ON, Jan. 5 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that it has received clearance from Canadian regulatory authorities to initiate two Phase II, double-blind, randomized trials for nimotuzumab, its EGFR-targeting antibody, in combination with radiation-based treatments. The Company will conduct a Phase II...

2008-09-02 12:00:34

PALO ALTO, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Two leading cancer centers have carried out groundbreaking radiosurgery treatments for multiple brain metastases using new RapidArc radiotherapy technology from Varian Medical Systems . The MIMA Cancer Center in Melbourne, Florida and VU University Medical Center in Amsterdam, Netherlands were each able to treat brain metastases more quickly and efficiently than would have previously been possible. Stereotactic radiosurgery is used to...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.